Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 59,440 shares at $65.86 ($3.8M) on 2024-05-15, disclosed to the SEC on 2024-05-17.
Scheduled sale ($3.8M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.86 | 14,850 | $978K | 25.7% |
| 2 | $63.84 | 16,459 | $1.1M | 27.6% |
| 3 | $63.84 | 16,459 | $1.1M | 27.6% |
| 4 | $62.09 | 5,836 | $362K | 9.5% |
| 5 | $62.09 | 5,836 | $362K | 9.5% |
| Total | $64.00 avg | 59,440 |
| $3.8M |
| 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |